SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-18-000019
Filing Date
2018-01-05
Accepted
2018-01-05 16:09:44
Documents
2
Period of Report
2018-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151518657112093.html 4  
1 FORM 4 wf-form4_151518657112093.xml 4 4090
2 POWER OF ATTORNEY - BOULDING ex-24.htm EX-24 4062
  Complete submission text file 0001070081-18-000019.txt   9635
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Boulding Mark Elliott (Reporting) CIK: 0001578852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 18513515